HYdroxychloroquine to Improve Pregnancy Outcome in Women with AnTIphospholipid Antibodies (HYPATIA) Protocol: A Multinational Randomized Controlled Trial of Hydroxychloroquine versus Placebo in Addition to Standard Treatment in Pregnant Women with Antiphospholipid Syndrome or Antibodies

ROCCATELLO, Dario;SCIASCIA, Savino;
2017-01-01

2017
43
6
562
571
http://www.thieme-connect.com/ejournals/toc/sth
antiphospholipid antibodies; antiphospholipid syndrome; hydroxychloroquine; obstetric antiphospholipid syndrome; pregnancy; Hematology; Cardiology and Cardiovascular Medicine
Schreiber, Karen; Breen, Karen; Cohen, Hannah; Jacobsen, Soren; Middeldorp, Saskia; Pavord, Sue; Regan, Lesley; Roccatello, Dario; Robinson, Susan E.; Sciascia, Savino; Seed, Paul T.; Watkins, Linda; Hunt, Beverley J
File in questo prodotto:
File Dimensione Formato  
s-0037-1603359.pdf

Accesso aperto

Tipo di file: PDF EDITORIALE
Dimensione 429.75 kB
Formato Adobe PDF
429.75 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1648000
Citazioni
  • ???jsp.display-item.citation.pmc??? 19
  • Scopus 77
  • ???jsp.display-item.citation.isi??? 74
social impact